[3,4-Dihydroxyphenylalanine (DOPA)]. 1995

S Shigetomi, and S Fukuchi
Third Department of Internal Medicine, Fukushima Medical College.

UI MeSH Term Description Entries
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D004295 Dihydroxyphenylalanine A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. Dopa,3,4-Dihydroxyphenylalanine,3-Hydroxy-DL-tyrosine,Dihydroxyphenylalanine Hydrochloride, (2:1),beta-Hydroxytyrosine,3 Hydroxy DL tyrosine,3,4 Dihydroxyphenylalanine,beta Hydroxytyrosine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Shigetomi, and S Fukuchi
December 1999, Nihon rinsho. Japanese journal of clinical medicine,
S Shigetomi, and S Fukuchi
November 1979, The Biochemical journal,
S Shigetomi, and S Fukuchi
November 1978, Clinical chemistry,
S Shigetomi, and S Fukuchi
February 1948, Journal of the American Chemical Society,
S Shigetomi, and S Fukuchi
January 1967, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
S Shigetomi, and S Fukuchi
October 1962, Lancet (London, England),
S Shigetomi, and S Fukuchi
September 1972, Biochemical pharmacology,
S Shigetomi, and S Fukuchi
November 1972, Chemical & pharmaceutical bulletin,
S Shigetomi, and S Fukuchi
July 1992, Clinical science (London, England : 1979),
S Shigetomi, and S Fukuchi
January 1962, Proceedings of the Western Pharmacology Society,
Copied contents to your clipboard!